These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38837386)

  • 1. Functional and esthetic effects of botulinum toxin injection into the masseter muscles: evaluation of 80 patients from a dermatological perspective.
    Ozdemir Cetinkaya P; Karaosmanoglu N; Özkesici Kurt B; Aksu Cerman A; Altunay IK
    Int J Dermatol; 2024 Jun; ():. PubMed ID: 38837386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects.
    Quezada-Gaon N; Wortsman X; Peñaloza O; Carrasco JE
    J Cosmet Dermatol; 2016 Sep; 15(3):238-44. PubMed ID: 26799545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A treatment for contouring of the lower face.
    Park MY; Ahn KY; Jung DS
    Dermatol Surg; 2003 May; 29(5):477-83; discussion 483. PubMed ID: 12752514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Electromyographic Changes in a Patient with Masseter Hypertrophy and Muscle Pain after Botulinum Injections: A Case Report and 5 Months Follow-up.
    Bianco E; Tagliabue R; Mirabelli L; Maddalone M
    J Contemp Dent Pract; 2022 Feb; 23(2):226-231. PubMed ID: 35748454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical investigation of botulinum toxin (prabotulinumtoxin A) for bruxism related to masseter muscle hypertrophy: A prospective study.
    Jung BK; Park H; Cheon YW; Yun IS; Choi JW; Kim HJ; Lee MY; Kang BS; Kang TJ
    J Craniomaxillofac Surg; 2023 May; 51(5):332-337. PubMed ID: 37353404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Efficacy of Low-Dose Botulinum Toxin Injection Into the Masseter Muscle for the Treatment of Nocturnal Bruxism: A Randomized Controlled Clinical Trial.
    Shehri ZG; Alkhouri I; Hajeer MY; Haddad I; Abu Hawa MH
    Cureus; 2022 Dec; 14(12):e32180. PubMed ID: 36474649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of masseter hypertrophy for tailored botulinum toxin type A treatment.
    Xie Y; Zhou J; Li H; Cheng C; Herrler T; Li Q
    Plast Reconstr Surg; 2014 Aug; 134(2):209e-218e. PubMed ID: 25068343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of botulinum toxin in masseter muscle hypertrophy for lower face contouring.
    Kundu N; Kothari R; Shah N; Sandhu S; Tripathy DM; Galadari H; Gold MH; Goldman MP; Kassir M; Schepler H; Grabbe S; Goldust M
    J Cosmet Dermatol; 2022 May; 21(5):1849-1856. PubMed ID: 35176198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic change and facial contour following botulinum toxin A injection in square faces.
    Lee CJ; Kim SG; Kim YJ; Han JY; Choi SH; Lee SI
    Plast Reconstr Surg; 2007 Sep; 120(3):769-778. PubMed ID: 17700130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications of botulinum toxin injection for masseter hypertrophy: Incidence rate from 2036 treatments and summary of causes and preventions.
    Peng HP; Peng JH
    J Cosmet Dermatol; 2018 Feb; 17(1):33-38. PubMed ID: 29250900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Literature review of the adverse events associated with botulinum toxin injection for the masseter muscle hypertrophy.
    Yeh YT; Peng JH; Peng HP
    J Cosmet Dermatol; 2018 Oct; 17(5):675-687. PubMed ID: 30091170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy.
    Klein FH; Brenner FM; Sato MS; Robert FM; Helmer KA
    An Bras Dermatol; 2014; 89(6):878-84. PubMed ID: 25387491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Masseter Muscle and Its Role in Facial Contouring, Aging, and Quality of Life: A Literature Review.
    Almukhtar RM; Fabi SG
    Plast Reconstr Surg; 2019 Jan; 143(1):39e-48e. PubMed ID: 30303926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evaluation of the Relationship between Changes in Masseter Muscle Thickness and Tooth Clenching Habits of Bruxism Patients Treated with Botulinum Toxin A.
    Erdil D; Bagis N; Eren H; Camgoz M; Orhan K
    J Med Ultrasound; 2023; 31(1):22-28. PubMed ID: 37180633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of Botulinum Toxin in Patients with Secondary Otalgia Caused by Bruxism.
    Kef K
    J Pain Res; 2021; 14():1051-1059. PubMed ID: 33907453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review on bigonial width reduction by botulinum toxin injections in masseter.
    Sharad Ghatge A; Balasaheb Ghatge S; Mehta V
    Bioinformation; 2023; 19(3):272-277. PubMed ID: 37808377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum Toxin Injections for Masseter Reduction in East Asians.
    Cheng J; Hsu SH; McGee JS
    Dermatol Surg; 2019 Apr; 45(4):566-572. PubMed ID: 30883483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ultrasound-assisted botulinum neurotoxin-A injection in patients with bruxism and masseter hypertrophy.
    Diracoglu D; Sahbaz T; Alptekin K; Dogan N
    Turk J Phys Med Rehabil; 2021 Sep; 67(3):351-356. PubMed ID: 34870123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of two formulations of botulinum toxin type A for masseter reduction: a split-face comparison study.
    Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Sathaworawong A; Lektrakul N; Manuskiatti W
    J Dermatolog Treat; 2017 Aug; 28(5):443-446. PubMed ID: 27884065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Botulinum Toxin in Treating Asian Indian Patients with Masseter Hypertrophy: A 4-Year Follow-Up Study.
    Shome D; Khare S; Kapoor R
    Plast Reconstr Surg; 2019 Sep; 144(3):390e-396e. PubMed ID: 31461011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.